Showing results (171-180 of 606) with videos related to
Sort By:
Pageof 61
Leukemia Research|October 16, 2015
Targeting bone marrow lymphoid niches in acute lymphoblastic leukemiaGeoffrey L Uy, Yen-Michael S Hsu, Amy P Schmidt, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 22, 2017
Fresh or Cryopreserved CD34+-Selected Mobilized Peripheral Blood Stem and Progenitor Cells for the Treatment of Poor Graft Function after Allogeneic Hematopoietic Cell TransplantationArmin Ghobadi, Mark A Fiala, Giridharan Ramsingh, et al.Scientific Reports|September 30, 2021
A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myelomaKinan Alhallak, Amanda Jeske, Pilar de la Puente, et al.Oncotarget|September 22, 2021
Nanoparticle T cell engagers for the treatment of acute myeloid leukemiaKinan Alhallak, Jennifer Sun, Barbara Muz, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2010
Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myelomaPatrick J Stiff, Ivana Micallef, Auayporn P Nademanee, et al.Blood|April 23, 2008
Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interactionSteven M Devine, Ravi Vij, Michael Rettig, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2017
T Cell-Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid LeukemiaJoan How, Michael Slade, Khoan Vu, et al.Clinical Lymphoma, Myeloma & Leukemia|April 6, 2015
Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, combined with daunorubicin and cytarabine in patients with poor-risk acute myeloid leukemia--results of a phase I dose-escalation studyJohn F DiPersio, Harry P Erba, Richard A Larson, et al.IEEE Transactions on Visualization and Computer Graphics|September 6, 2018
Identification of Temporally Varying Areas of Interest in Long-Duration Eye-Tracking Data SetsPrithiviraj K Muthumanickam, Katerina Vrotsou, Aida Nordman, et al.Journal of Surgical Case Reports|April 28, 2023
The transplant ureter causing small bowel obstruction following intraperitoneal kidney transplantation: a case reportMotaz A Selim, Ashley Krepline, Calvin Eriksen, et al.Pageof 61